Levetiracetam
Product Images NDC 17856-0685

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 17856-0685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

690afec4-figure-01 (Levetiracetam Oral Solution 1)

690afec4-figure-01 (Levetiracetam Oral Solution 1)
FDA Label Image

690afec4-figure-02 (Levetiracetam Oral Solution 2)

690afec4-figure-02 (Levetiracetam Oral Solution 2)
FDA Label Image

690afec4-figure-03 (Levetiracetam Oral Solution 3)

690afec4-figure-03 (Levetiracetam Oral Solution 3)
FDA Label Image

690afec4-figure-04 (Levetiracetam Oral Solution 4)

690afec4-figure-04 (Levetiracetam Oral Solution 4)
FDA Label Image

690afec4-figure-05 (Levetiracetam Oral Solution 5)

690afec4-figure-05 (Levetiracetam Oral Solution 5)
This text appears to be a table or graph showing two percentages (44.6% and 19.6%) and how they correspond to patients taking a placebo or levetiracetam. However, without additional context, it is not possible to determine what these percentages represent or what condition or study they may relate to.*
FDA Label Image

690afec4-figure-06 (Levetiracetam Oral Solution 6)

690afec4-figure-06 (Levetiracetam Oral Solution 6)
FDA Label Image

690afec4-figure-07 (Levetiracetam Oral Solution 7)

690afec4-figure-07 (Levetiracetam Oral Solution 7)
FDA Label Image

Label Image (Rspl17856 0685)

Label Image (Rspl17856 0685)
This is an oral solution medication of LevETIRACETAM, available only through a prescription. Each 5 mL of the solution contains 500 mg of the medication. The medication is distributed by Atlantic Biologicals and the package is manufactured by Actavis-Mfg. The lot number is given as XXXXXX and the expiration date is 04/17/13. The package is delivered in 5 mL doses and it is packaged by UDOSE LLC located in Miami, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.